Reconsidering the Current Preterm Premature Rupture of Membranes Antibiotic Prophylactic Protocol

Abstract

Objective The purpose of our study was to determine whether the current antibiotic regimen for preterm premature rupture of membranes (PPROM) is adequate for covering the current causative agents and sensitivities of chorioamnionitis and early-onset neonatal sepsis.

Study Design During a 3-year period, we retrieved the results from placental and amniotic membrane cultures obtained at delivery in cases of maternal fever, chorioamnionitis, and PPROM, and from blood cultures obtained from neonates with early-onset sepsis (EOS) in three participating hospitals. Sensitivity of pathogens to antimicrobial agents was performed using routine microbiologic techniques.

Results There were 1,133 positive placental or amniotic cultures, 740 (65.3%) were from gram-negative Enterobacteriaceae. There were 27 neonates diagnosed with EOS with positive blood cultures. Aerobic Enterobacteriaceae accounted for 14 cases (52%) and group B streptococcus for 7 cases (26%). Of the Escherichia coli and Klebsiella sp., only 38% were sensitive to ampicillin.

Conclusion Local pathogens and their antibiotic sensitivity profiles should be explored every few years and an effective antibiotic protocol chosen to cover the main pathogens causing chorioamnionitis and EOS. Consideration should be made for changing ampicillin in women with PPROM to a regimen with better coverage of gram-negative Enterobacteriaceae.

Keywords

early-onset sepsis - preterm premature rupture of membranes - chorioamnionitis - antibiotic therapy - gram-negative bacteria

• References

• 1 Mercer BM. Preterm premature rupture of the membranes: current approaches to evaluation and management. Obstet Gynecol Clin North Am 2005; 32 (3) 411-428
• 2 Newton ER. Chorioamnionitis and intraamniotic infection. Clin Obstet Gynecol 1993; 36 (4) 795-808
• 3 Sperling RS, Newton E, Gibbs RS. Intraamniotic infection in low-birth-weight infants. J Infect Dis 1988; 157 (1) 113-117
• 4 Practice bulletins No. 139: premature rupture of membranes. Obstet Gynecol 2013; 122 (4) 918-930
• 5 Carlan SJ, O'Brien WF, Parsons MT, Lense JJ. Preterm premature rupture of membranes: a randomized study of home versus hospital management. Obstet Gynecol 1993; 81 (1) 61-64
• 6 Turnbull DA, Wilkinson C, Gerard K , et al. Clinical, psychosocial, and economic effects of antenatal day care for three medical complications of pregnancy: a randomised controlled trial of 395 women. Lancet 2004; 363 (9415) 1104-1109
• 7 Roberts D, Dalziel S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev 2006; 3 (3) CD004454
• 8 Harding JE, Pang J, Knight DB, Liggins GC. Do antenatal corticosteroids help in the setting of preterm rupture of membranes?. Am J Obstet Gynecol 2001; 184 (2) 131-139
• 9 Kenyon S, Boulvain M, Neilson JP. Antibiotics for preterm rupture of membranes. Cochrane Database Syst Rev 2013; 12: CD001058
• 10 Mercer BM, Miodovnik M, Thurnau GR , et al; National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Antibiotic therapy for reduction of infant morbidity after preterm premature rupture of the membranes. A randomized controlled trial. JAMA 1997; 278 (12) 989-995
• 11 Workowski KA, Berman S ; Centers for Disease Control and Prevention (CDC). Sexually transmitted diseases treatment guidelines, 2010. MMWR Recomm Rep 2010; 59 (RR-12): 1-110
• 12 Grigsby PL, Novy MJ, Sadowsky DW , et al. Maternal azithromycin therapy for Ureaplasma intraamniotic infection delays preterm delivery and reduces fetal lung injury in a primate model. Am J Obstet Gynecol 2012; 207 (6) 475.e1-475.e14
• 13 Stoll BJ, Hansen NI, Sánchez PJ , et al; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Early onset neonatal sepsis: the burden of group B Streptococcal and E. coli disease continues. Pediatrics 2011; 127 (5) 817-826
• 14 Sgro M, Shah PS, Campbell D, Tenuta A, Shivananda S, Lee SK ; Canadian Neonatal Network. Early-onset neonatal sepsis: rate and organism pattern between 2003 and 2008. J Perinatol 2011; 31 (12) 794-798
• 15 Vergnano S, Menson E, Kennea N , et al. Neonatal infections in England: the NeonIN surveillance network. Arch Dis Child Fetal Neonatal Ed 2011; 96 (1) F9-F14
• 16 Rønnestad A, Abrahamsen TG, Medbø S , et al. Septicemia in the first week of life in a Norwegian national cohort of extremely premature infants. Pediatrics 2005; 115 (3) e262-e268
• 17 Maayan-Metzger A, Barzilai A, Keller N, Kuint J. Are the “good old” antibiotics still appropriate for early-onset neonatal sepsis? A 10 year survey. Isr Med Assoc J 2009; 11 (3) 138-142
• 18 Schrag SJ, Hadler JL, Arnold KE, Martell-Cleary P, Reingold A, Schuchat A. Risk factors for invasive, early-onset Escherichia coli infections in the era of widespread intrapartum antibiotic use. Pediatrics 2006; 118 (2) 570-576
• 19 Clark RH, Bloom BT, Spitzer AR, Gerstmann DR. Empiric use of ampicillin and cefotaxime, compared with ampicillin and gentamicin, for neonates at risk for sepsis is associated with an increased risk of neonatal death. Pediatrics 2006; 117 (1) 67-74
• 20 Edwards RK, Jamie WE, Sterner D, Gentry S, Counts K, Duff P. Intrapartum antibiotic prophylaxis and early-onset neonatal sepsis patterns. Infect Dis Obstet Gynecol 2003; 11 (4) 221-226
• 21 Laugel V, Kuhn P, Beladdale J , et al. Effects of antenatal antibiotics on the incidence and bacteriological profile of early-onset neonatal sepsis. A retrospective study over five years. Biol Neonate 2003; 84 (1) 24-30
• 22 Cape A, Tuomala RE, Taylor C, Puopolo KM. Peripartum bacteremia in the era of group B streptococcus prophylaxis. Obstet Gynecol 2013; 121 (4) 812-818